Literature DB >> 22585495

Two-dimensional difference gel electrophoresis.

Jonathan S Minden1.   

Abstract

Two-dimensional difference gel electrophoresis (2D DIGE) is a modified form of 2D electrophoresis (2DE) that allows one to compare two or three protein samples simultaneously on the same gel. The proteins in each sample are covalently tagged with different color fluorescent dyes that are designed to have no effect on the relative migration of proteins during electrophoresis. Proteins that are common to the samples appear as "spots" with a fixed ratio of fluorescent signals, whereas proteins that differ between the samples have different fluorescence ratios. With the appropriate imaging system, difference gel electrophoresis (DIGE) is capable of reliably detecting as little as 0.2 fmol of protein, and protein differences down to ±15%, over a ∼20,000-fold protein concentration range. DIGE combined with digital image analysis therefore greatly improves the statistical assessment of proteome variation. Here we describe a protocol for conducting DIGE experiments, which takes 2-3 days to complete.

Mesh:

Substances:

Year:  2012        PMID: 22585495     DOI: 10.1007/978-1-61779-821-4_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.

Authors:  Svitlana Yablonska; Vinitha Ganesan; Lisa M Ferrando; JinHo Kim; Anna Pyzel; Oxana V Baranova; Nicolas K Khattar; Timothy M Larkin; Sergei V Baranov; Ning Chen; Colleen E Strohlein; Donté A Stevens; Xiaomin Wang; Yue-Fang Chang; Mark E Schurdak; Diane L Carlisle; Jonathan S Minden; Robert M Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

2.  Proteomic analysis reveals APC-dependent post-translational modifications and identifies a novel regulator of β-catenin.

Authors:  Malachi A Blundon; Danielle R Schlesinger; Amritha Parthasarathy; Samantha L Smith; Hannah M Kolev; David A Vinson; Ezgi Kunttas-Tatli; Brooke M McCartney; Jonathan S Minden
Journal:  Development       Date:  2016-06-10       Impact factor: 6.868

3.  Immuno-proteomics: Development of a novel reagent for separating antibodies from their target proteins.

Authors:  Vinitha Ganesan; Brigitte Schmidt; Raghunandan Avula; Dagney Cooke; Taylor Maggiacomo; Lawton Tellin; Dana P Ascherman; Marcel P Bruchez; Jonathan Minden
Journal:  Biochim Biophys Acta       Date:  2014-10-22

4.  Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.

Authors:  Uzoma K Iheagwara; Pamela L Beatty; Phu T Van; Ted M Ross; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2013-12-05       Impact factor: 11.151

5.  Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention.

Authors:  Camille Jacqueline; Amanda Lee; Nolan Frey; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2020-05-28       Impact factor: 11.151

Review 6.  Comparative Skeletal Muscle Proteomics Using Two-Dimensional Gel Electrophoresis.

Authors:  Sandra Murphy; Paul Dowling; Kay Ohlendieck
Journal:  Proteomes       Date:  2016-09-09

7.  LCVM infection generates tumor antigen-specific immunity and inhibits growth of nonviral tumors.

Authors:  Camille Jacqueline; Matthew Dracz; Jia Xue; Robert J Binder; Jonathan Minden; Olivera Finn
Journal:  Oncoimmunology       Date:  2022-01-21       Impact factor: 7.723

8.  Identification of Cell Surface Molecules That Determine the Macrophage Activation Threshold Associated With an Early Stage of Malignant Transformation.

Authors:  Camille Jacqueline; Matthew Dracz; Sarah Boothman; Jonathan S Minden; Rachel A Gottschalk; Olivera J Finn
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 8.786

Review 9.  Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Authors:  Ashling Holland; Kay Ohlendieck
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

10.  Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research.

Authors:  Steven Carberry; Margit Zweyer; Dieter Swandulla; Kay Ohlendieck
Journal:  Biology (Basel)       Date:  2013-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.